| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |